ID	Database	Citation
29602400	Pubmed	"Shayman JA. Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal Disease. Semin Nephrol. 2018 Mar;38(2):183–92.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/29602400"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/29602400"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/29602400"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
33630410	Pubmed	"Sen P, Hyötyläinen T, Orešič M. 1-Deoxyceramides - Key players in lipotoxicity and progression to type 2 diabetes? Acta Physiol (Oxf). 2021 May;232(1):e13635.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/33630410"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/33630410"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/33630410"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
33673027	Pubmed	"Chatterjee S, Balram A, Li W. Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes. Int J Mol Sci. 2021 Feb 12;22(4):1816.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/33673027"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/33673027"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/33673027"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
